KIORA PHARMACEUTICALS, INC. Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest
KIORA PHARMACEUTICALS, INC. (KPRX) reported Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$2.11 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-07
- KIORA PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$2.11M.
- KIORA PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$2.40M.
- KIORA PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$6.52M.
- KIORA PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was $28.87K.
- KIORA PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2025 was -$10.80M, a 408.95% decline from fiscal 2024.
- KIORA PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was $3.50M.
- KIORA PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was -$12.51M.
- KIORA PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was -$13.68M.
| Period end | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.11M 10-Q · filed 2026-08-07 | -$4.51M 10-Q · filed 2026-08-07 | -$11.03M derived: sum of 3 quarters · filed 2026-08-07 | -$11.00M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | -$2.40M 10-Q · filed 2026-05-08 | -$8.92M derived: sum of 2 quarters · filed 2026-05-08 | -$8.89M derived: sum of 3 quarters · filed 2026-05-08 | -$10.99M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | -$6.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$6.49M derived: sum of 2 quarters · filed 2026-03-25 | -$8.59M derived: sum of 3 quarters · filed 2026-08-07 | -$10.80M 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $28.87K 10-Q · filed 2025-11-07 | -$2.07M derived: sum of 2 quarters · filed 2026-08-07 | -$4.28M 10-Q · filed 2025-11-07 | -$8.71M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | -$2.10M 10-Q · filed 2026-08-07 | -$4.31M 10-Q · filed 2026-08-07 | -$8.74M derived: sum of 3 quarters · filed 2026-08-07 | -$11.98M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | -$2.21M 10-Q · filed 2026-05-08 | -$6.64M derived: sum of 2 quarters · filed 2026-05-08 | -$9.88M derived: sum of 3 quarters · filed 2026-05-08 | -$12.08M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | -$4.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$7.67M derived: sum of 2 quarters · filed 2026-03-25 | -$9.88M derived: sum of 3 quarters · filed 2026-03-25 | $3.50M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | -$3.24M 10-Q · filed 2025-11-07 | -$5.45M derived: sum of 2 quarters · filed 2025-11-07 | $7.93M 10-Q · filed 2025-11-07 | $5.74M derived: sum of 4 quarters · filed 2025-11-07 | ||||
| 2024-06-30 | -$2.20M 10-Q · filed 2025-08-08 | $11.17M 10-Q · filed 2025-08-08 | $8.98M derived: sum of 3 quarters · filed 2025-08-08 | $3.18M derived: sum of 4 quarters · filed 2025-08-08 | ||||
| 2024-03-31 | $13.37M 10-Q · filed 2025-05-09 | $11.19M derived: sum of 2 quarters · filed 2025-05-09 | $5.38M derived: sum of 3 quarters · filed 2025-05-09 | $2.76M derived: sum of 4 quarters · filed 2025-05-09 | ||||
| 2023-12-31 | -$2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | -$7.99M derived: sum of 2 quarters · filed 2025-03-25 | -$10.61M derived: sum of 3 quarters · filed 2025-03-25 | -$12.51M 10-K · filed 2025-03-25 | ||||
| 2023-09-30 | -$5.80M 10-Q · filed 2024-11-08 | -$8.43M derived: sum of 2 quarters · filed 2024-11-08 | -$10.33M 10-Q · filed 2024-11-08 | -$12.75M derived: sum of 4 quarters · filed 2024-11-08 | ||||
| 2023-06-30 | -$2.62M 10-Q · filed 2024-08-09 | -$4.53M 10-Q · filed 2024-08-09 | -$6.94M derived: sum of 3 quarters · filed 2024-08-09 | -$12.10M derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | -$1.90M 10-Q · filed 2024-05-10 | -$4.32M derived: sum of 2 quarters · filed 2024-05-10 | -$9.48M derived: sum of 3 quarters · filed 2024-05-10 | -$12.04M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | -$2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$7.58M derived: sum of 2 quarters · filed 2024-03-25 | -$10.14M derived: sum of 3 quarters · filed 2024-03-25 | -$13.68M 10-K · filed 2024-03-25 | ||||
| 2022-09-30 | -$5.16M 10-Q · filed 2023-11-09 | -$7.72M derived: sum of 2 quarters · filed 2023-11-09 | -$11.26M 10-Q · filed 2023-11-09 | -$17.47M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$2.57M 10-Q · filed 2023-08-08 | -$6.10M 10-Q · filed 2023-08-08 | -$12.31M derived: sum of 3 quarters · filed 2023-08-08 | -$15.39M derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | -$3.54M 10-Q · filed 2023-05-09 | -$9.75M derived: sum of 2 quarters · filed 2023-05-09 | -$12.83M derived: sum of 3 quarters · filed 2023-05-09 | -$15.39M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | -$6.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$9.29M derived: sum of 2 quarters · filed 2023-03-23 | -$11.86M derived: sum of 3 quarters · filed 2023-03-23 | -$13.86M 10-K · filed 2023-03-23 | -$16.48M 10-K · filed 2022-04-15 | |||
| 2021-09-30 | -$3.08M 10-Q · filed 2022-11-09 | -$3.01M 10-Q · filed 2021-11-15 | -$5.65M derived: sum of 2 quarters · filed 2022-11-09 | -$7.65M 10-Q · filed 2022-11-09 | -$8.08M 10-Q · filed 2021-11-15 | -$8.96M derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | -$2.57M 10-Q · filed 2022-08-12 | -$2.49M 10-Q · filed 2021-08-12 | -$4.57M 10-Q · filed 2022-08-12 | -$5.06M 10-Q · filed 2021-08-12 | -$5.88M derived: sum of 3 quarters · filed 2022-08-12 | -$7.90M derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2021-03-31 | -$2.00M 10-Q · filed 2022-07-08 | -$2.57M 10-Q · filed 2021-05-12 | -$3.31M derived: sum of 2 quarters · filed 2022-07-08 | -$5.33M derived: sum of 3 quarters · filed 2022-07-08 | -$7.05M derived: sum of 4 quarters · filed 2022-07-08 | |||
| 2020-12-31 | -$1.31M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-07 | -$3.33M derived: sum of 2 quarters · filed 2022-07-07 | -$5.05M derived: sum of 3 quarters · filed 2022-07-07 | -$7.00M 10-K/A · filed 2022-07-07 | -$8.23M 10-K · filed 2021-03-25 | |||
| 2020-09-30 | -$2.02M 10-Q · filed 2021-11-15 | -$3.74M derived: sum of 2 quarters · filed 2021-11-15 | -$5.69M 10-Q · filed 2021-11-15 | -$8.39M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | -$1.72M 10-Q · filed 2021-08-12 | -$3.67M 10-Q · filed 2021-08-12 | -$6.37M derived: sum of 3 quarters · filed 2021-08-12 | -$9.80M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$1.95M 10-Q · filed 2021-05-12 | -$4.65M derived: sum of 2 quarters · filed 2021-05-12 | -$8.08M derived: sum of 3 quarters · filed 2021-05-12 | -$9.91M derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | -$2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$6.13M derived: sum of 2 quarters · filed 2021-03-25 | -$7.96M derived: sum of 3 quarters · filed 2021-03-25 | -$7.09M 10-K · filed 2021-03-25 | ||||
| 2019-09-30 | -$3.43M 10-Q · filed 2020-11-09 | -$5.26M derived: sum of 2 quarters · filed 2020-11-09 | -$4.39M 10-Q · filed 2020-11-09 | -$6.92M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | -$1.84M 10-Q · filed 2020-08-06 | -$965.61K 10-Q · filed 2020-08-06 | -$3.50M derived: sum of 3 quarters · filed 2020-08-06 | -$6.61M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $870.31K 10-Q · filed 2020-05-06 | -$1.66M derived: sum of 2 quarters · filed 2020-05-06 | -$4.78M derived: sum of 3 quarters · filed 2020-05-06 | -$7.56M derived: sum of 4 quarters · filed 2020-05-06 | ||||
| 2018-12-31 | -$2.53M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | -$5.65M derived: sum of 2 quarters · filed 2020-03-04 | -$8.43M derived: sum of 3 quarters · filed 2020-03-04 | -$10.80M 10-K · filed 2020-03-04 | ||||
| 2018-09-30 | -$3.12M 10-Q · filed 2019-11-07 | -$5.90M derived: sum of 2 quarters · filed 2019-11-07 | -$8.27M 10-Q · filed 2019-11-07 | -$11.10M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | -$2.78M 10-Q · filed 2019-08-08 | -$5.16M 10-Q · filed 2019-08-08 | -$7.99M derived: sum of 3 quarters · filed 2019-08-08 | -$12.12M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | -$2.38M 10-Q · filed 2019-05-08 | -$5.21M derived: sum of 2 quarters · filed 2019-05-08 | -$9.35M derived: sum of 3 quarters · filed 2019-05-08 | -$12.67M derived: sum of 4 quarters · filed 2019-05-08 | ||||
| 2017-12-31 | -$2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$6.97M derived: sum of 2 quarters · filed 2019-03-01 | -$10.29M derived: sum of 3 quarters · filed 2019-03-01 | -$13.21M 10-K · filed 2019-03-01 | ||||
| 2017-09-30 | -$4.14M 10-Q · filed 2018-11-13 | -$7.46M derived: sum of 2 quarters · filed 2018-11-13 | -$10.38M 10-Q · filed 2018-11-13 | -$14.08M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | -$3.32M 10-Q · filed 2018-08-03 | -$6.24M 10-Q · filed 2018-08-03 | -$9.94M derived: sum of 3 quarters · filed 2018-08-03 | -$13.31M derived: sum of 4 quarters · filed 2018-08-03 | ||||
| 2017-03-31 | -$2.92M 10-Q · filed 2018-05-11 | -$6.61M derived: sum of 2 quarters · filed 2018-05-11 | -$9.99M derived: sum of 3 quarters · filed 2018-05-11 | -$13.81M derived: sum of 4 quarters · filed 2018-05-11 | ||||
| 2016-12-31 | -$3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | -$7.07M derived: sum of 2 quarters · filed 2018-03-02 | -$10.90M derived: sum of 3 quarters · filed 2018-03-02 | -$13.34M 10-K · filed 2018-03-02 | ||||
| 2016-09-30 | -$3.38M 10-Q · filed 2017-11-14 | -$7.20M derived: sum of 2 quarters · filed 2017-11-14 | -$9.64M 10-Q · filed 2017-11-14 | -$12.32M derived: sum of 4 quarters · filed 2017-11-14 | ||||
| 2016-06-30 | -$3.82M 10-Q · filed 2017-08-04 | -$6.27M 10-Q · filed 2017-08-04 | -$8.94M derived: sum of 3 quarters · filed 2017-08-04 | -$10.30M derived: sum of 4 quarters · filed 2017-08-04 | ||||
| 2016-03-31 | -$2.44M 10-Q · filed 2017-05-05 | -$5.12M derived: sum of 2 quarters · filed 2017-05-05 | -$6.48M derived: sum of 3 quarters · filed 2017-05-05 | -$7.99M derived: sum of 4 quarters · filed 2017-05-05 | ||||
| 2015-12-31 | -$2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$4.04M derived: sum of 2 quarters · filed 2017-02-23 | -$5.55M derived: sum of 3 quarters · filed 2017-02-23 | -$8.30M 10-K · filed 2017-02-23 | ||||
| 2015-09-30 | -$1.36M 10-Q · filed 2016-11-01 | -$2.87M derived: sum of 2 quarters · filed 2016-11-01 | -$5.62M 10-Q · filed 2016-11-01 | |||||
| 2015-06-30 | -$1.51M 10-Q · filed 2016-08-10 | -$4.26M 10-Q · filed 2016-08-10 | ||||||
| 2015-03-31 | -$2.75M 10-Q · filed 2015-05-18 | |||||||
| 2014-09-30 | $347.65K 10-Q · filed 2015-11-12 | -$313.36K derived: sum of 2 quarters · filed 2015-11-12 | -$1.21M 10-Q · filed 2015-11-12 | |||||
| 2014-06-30 | -$661.00K 10-Q · filed 2015-08-12 | -$1.55M 10-Q · filed 2015-08-12 | ||||||
| 2014-03-31 | -$911.89K 10-Q · filed 2015-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |